We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Low-Cost Medical Device Stops Postpartum Hemorrhages

By HospiMedica International staff writers
Posted on 24 Sep 2025

Postpartum hemorrhage is one of the leading causes of maternal mortality, particularly in low-resource regions where access to advanced healthcare is limited. More...

Treating the condition quickly is critical, yet existing solutions are often too expensive, complex, or unavailable in high-risk settings. Now, researchers have developed a low-cost, easy-to-use medical device designed to stop uterine bleeding immediately after childbirth.

The device, called BAMBI (Balloon Against Maternal Bleeding), has been developed by a multidisciplinary research team at the Politecnico di Milano (Milan, Italy). The prototype consists of a simple kit made from widely available components, including a rectal probe, probe cover, and a saline bag fitted with a clamp. Its key feature is a patented connector that ensures the system is safe, easy to assemble, and mechanically reliable, making it both effective and affordable for use in resource-poor environments.

BAMBI works by inserting the probe into the uterus in cases of postpartum bleeding. Once positioned, the probe cover is inflated with saline solution to create a balloon that applies internal pressure, stopping the hemorrhage at its source. The design prioritizes accessibility and can be operated with printed or video instructions, allowing even non-specialized personnel to use it safely and effectively.

Extensive functional and usability testing showed that BAMBI is efficient in terms of procedural accuracy and assembly time. The findings, published in Scientific Reports, confirmed that the device works reliably even when used by individuals without medical training. This feature is especially critical in areas with weak healthcare infrastructure, where trained professionals may not be available.

The project is now moving toward mass production, with plans to manufacture the connector using injection molding to lower costs further. With an estimated cost of about USD 5 per unit, BAMBI is poised to be distributed widely in vulnerable communities. The research team aims to ensure global accessibility by waiving patent rights, supporting the device’s use wherever it is most urgently needed.

“With BAMBI, we want to show that it is possible to combine technological innovation with a social impact,” said Maria Laura Costantino, scientific coordinator of the BAMBI project and professor at the Politecnico di Milano. “Our goal is to offer a concrete, affordable, and safe solution to stop postpartum hemorrhaging. We aim to make this device available wherever it is needed, even in the most vulnerable situations, by using an essential, accessibility-oriented engineering approach and a “social” patent.”

Related Links:
Politecnico di Milano


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.